{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:24:48Z","timestamp":1768001088991,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.jaad.2004.01.058","type":"journal-article","created":{"date-parts":[[2004,7,8]],"date-time":"2004-07-08T11:14:16Z","timestamp":1089285256000},"page":"126-131","source":"Crossref","is-referenced-by-count":63,"title":["Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients"],"prefix":"10.1016","volume":"51","author":[{"given":"Julia C","family":"Sansbury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Cocuroccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph L","family":"Jorizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Gubinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Gisondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampiero","family":"Girolomoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2004.01.058_BIB1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1067\/mjd.2001.111630","article-title":"Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema","volume":"44","author":"Rongioletti","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.01.058_BIB2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0190-9622(95)90007-1","article-title":"Scleromyxedema","volume":"33","author":"Dinneen","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.01.058_BIB3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-4362.2003.01565.x","article-title":"Scleromyxedema revisited","volume":"42","author":"Pomann","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2004.01.058_BIB4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0733-8635(02)00017-7","article-title":"Diffuse cutaneous mucinoses","volume":"20","author":"Jackson","year":"2002","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2004.01.058_BIB5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0190-9622(00)70305-7","article-title":"Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIG)","volume":"43","author":"Lister","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.01.058_BIB6","first-page":"201","article-title":"The dermal mucinoses","volume":"8","author":"Stephens","year":"1993","journal-title":"Adv Dermatol"},{"key":"10.1016\/j.jaad.2004.01.058_BIB7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0190-9622(00)90274-3","article-title":"Scleromyxedema with dermato-neuro syndrome","volume":"42","author":"Gonzales","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.01.058_BIB8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00000372-200106000-00022","article-title":"Cutaneous mucinosis: microscopic criteria for diagnosis","volume":"23","author":"Rongioletti","year":"2001","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2004.01.058_BIB9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0190-9622(98)70567-5","article-title":"Fatal scleromyxedema: report of a case and review of the literature","volume":"38","author":"Godby","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.01.058_BIB10","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","article-title":"Antitumor activity of thalidomide in refractory multiple myeloma","volume":"341","author":"Singhal","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.01.058_BIB11","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood-2002-05-1527","article-title":"Efficacy of low dose of thalidomide in advanced multiple myeloma","volume":"100","author":"Leleu","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2004.01.058_BIB12","first-page":"487","article-title":"Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide","volume":"11","author":"Atra","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2004.01.058_BIB13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0145-2126(02)00036-X","article-title":"Thalidomide in the treatment of myelodysplastic syndrome with fibrosis","volume":"26","author":"Tsirigotis","year":"2002","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaad.2004.01.058_BIB14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2249.1995.tb05527.x","article-title":"The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures","volume":"99","author":"McHugh","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2004.01.058_BIB15","first-page":"77","article-title":"Thalidomide: from tragedy to promise","volume":"133","author":"Von Moos","year":"2003","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jaad.2004.01.058_BIB16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.med.53.082901.104043","article-title":"Thalidomide: emerging role in cancer medicine","volume":"53","author":"Richardson","year":"2002","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jaad.2004.01.058_BIB17","first-page":"1","article-title":"Medical use of thalidomide: past, present and future","volume":"36","author":"Lu","year":"2002","journal-title":"Dermatol Found"},{"key":"10.1016\/j.jaad.2004.01.058_BIB18","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1046\/j.1523-1747.2002.19502.x","article-title":"Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients","volume":"119","author":"Bastuji-Garin","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2004.01.058_BIB19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1067\/mjd.2003.87","article-title":"Dermatologic side effects of thalidomide in patients with multiple myeloma","volume":"48","author":"Hall","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.01.058_BIB20","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1182\/blood-2001-12-0245","article-title":"Thromboembolic events during treatment with thalidomide","volume":"99","author":"Urbauer","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2004.01.058_BIB21","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1182\/blood-2002-01-0335","article-title":"Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy","volume":"100","author":"Zangari","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2004.01.058_BIB22","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1182\/blood-2002-06-1674","article-title":"Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy","volume":"100","author":"Cavo","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2004.01.058_BIB23","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1056\/NEJM200106213442516","article-title":"Deep venous thrombosis and thalidomide therapy for multiple myeloma","volume":"344","author":"Osman","year":"2001","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1016\/j.jaad.2004.07.010","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000}}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204007376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204007376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T21:27:07Z","timestamp":1549402027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962204007376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0190962204007376"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2004.01.058","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}